Aquaculture Feed and Pharmaceutical Market
Aquaculture Feed and Pharmaceutical Market Analysis by Pharmaceuticals & Biologics and Medicated Feed for Molluscs, Shrimp, Salmon, Carp, Tilapia, and Catfish from 2024 to 2034
Analysis of Aquaculture Feed and Pharmaceutical Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Aquaculture Feed and Pharmaceutical Market Outlook (2024 to 2034)
As per a new study by seasoned analysts at Fact.MR, the global aquaculture feed and pharmaceutical market size is pegged at US$ 999.4 million for 2024. Worldwide demand for aquaculture feed and pharmaceuticals is predicted to increase at 7.4% CAGR and reach a market valuation of US$ 2.04 billion by the end of 2034.
Increasing global population and shifting dietary preferences to healthier options are set to stimulate worldwide demand for seafood. Aquaculture is believed to be one of the prominent sources of seafood production. In parallel, demand for aquaculture feed and pharmaceuticals is rising at a significant pace.
Advancements in aquafeed formulations, additives, and pharmaceuticals are predicted to lead to improved fish health and disease prevention. Innovations in aquaculture feed and pharmaceuticals are predicted to improve sustainability and efficiency.
More consumers are becoming conscious about the production of sustainable seafood. This demand is predicted to lead to the production of eco-friendly aquaculture feed and pharmaceuticals to minimize environmental impacts, address issues about the use of antibiotics, and reduce waste.
Regulatory policies about aquaculture practices, pharmaceutical usage, and feed ingredients are foreseen to hinder market growth opportunities. Restrictions imposed on antibiotic use are predicted to lead to the adoption of alternative options, including organic feed, for disease management.
- Demand for aquaculture feed and pharmaceuticals in China is projected to increase at a CAGR of 7.8% and reach a market valuation of US$ 924.1 million by the end of 2034.
- The United States is predicted to account for 69% share of the North American market by 2034.
- Sales of pharmaceuticals & biologics are forecasted to rise at 7.2% CAGR and reach US$ 1.6 billion by 2034-end.
Health and disease challenges in aquaculture species are forecasted to create constant requirements for efficient disease management solutions. R&D activities in this field aim to address health issues and prevalent diseases among farmed aquatic species. In addition, increased investments in the aquaculture industry for technology, infrastructure, and R&D activities are projected to foster innovations in aquaculture feed and pharmaceuticals, enhancing their efficacy and quality.
| Report Attributes | Details |
|---|---|
| Aquaculture Feed and Pharmaceutical Market Size (2024E) | US$ 999.4 Million |
| Forecasted Market Value (2034F) | US$ 2.04 Billion |
| Global Market Growth Rate (2024 to 2034) | 7.4% CAGR |
| East Asia Market Share (2034F) | 50.1% |
| Demand Growth in Canada (2024 to 2034) | 7.5% CAGR |
| China Market Value (2034F) | US$ 924.1 Million |
| Carp Segment Value (2024E) | US$ 425.8 Million |
| Pharmaceuticals & Biologics Segment Share (2034F) | 78.5% |
| Key Companies Profiled | AgriProtein Holdings Ltd.; InnovaFeed; Beta Hatch; Nutrition Technologies Group; Mutatec; Zoetis, Inc.; Ridley Corporation Ltd.; Schouw & Co.; Merck & Co Inc.; Aller Aqua A/A; Biomin Holding GmbH; Avanti Feeds Ltd.; Alltech Inc.; Norel S.A.; Beneo GmbH; Akretting AS; Neovia Vietnam; Growel Feeds Pvt. Ltd.; Novus International Inc. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What is Aiding Aquaculture Feed and Pharmaceutical Market Growth?
“Rising Demand for Seafood across the World”
In recent years, there has been a noteworthy increase in the demand for seafood due to shifting dietary inclination to healthier food options. This transformation in dietary preferences is predicted to lead to the growing consumption of seafood owing to its recognized nutritional value and health benefits.
Aquaculture is predicted to emerge as a popular source of seafood production to match this increasing demand. Aquaculture generally involves farming of fish and similar aquatic organisms, which plays a significant role in matching the need for several seafood products. A controlled environment is provided for fish breeding, nurturing, and harvesting, ensuring a more reliable and sustainable supply of seafood in comparison to conventional fishing methods.
Certain supportive elements are required for the optimal growth and health of farmed fish. Adoption of high-quality feed can offer essential nutrients required for the proper development of aquatic species that are raised in captivity.
“Adoption of Sustainable Seafood Production Practices Amidst Rising Environmental Concerns”
Rising awareness about sustainability and environmental concerns in seafood production is predicted to influence industry practices and consumer behavior. More consumers are opting for seafood that aligns with sustainable and ethical practices. This paradigm shift is predicted to catalyze a noteworthy transformation in the aquaculture industry, stimulating the production and adoption of eco-friendly solutions aimed at reducing environmental impacts.
Conventional feed utilized in aquaculture generally contains ingredients that are sourced from wild fish, contributing to ecosystem imbalance and overfishing. Therefore, there is an emphasis on producing alternative feeds, which are derived from sustainable sources, including insects, plant-based proteins, and algae. These innovative feed formulations minimize the environmental footprint related to the production and distribution of feed. These initiatives are predicted to help foster a more sustainable and environment-friendly approach to the production of seafood, matching consumer expectations and safeguarding aquatic ecosystems for coming generations.
What is Expected to Limit Expansion Opportunities in the Market?
“Absence of Harmonization in Production Techniques Used for Veterinary Medicinal Products”
Several developed regions, including Europe, have varied laws defined for the development of veterinary medicines. For instance, in Germany, separate production lines are required to be installed for medicated feed and compound feed. In addition, there are also variations in the level of residue allowed for veterinary medicines across different countries. These differences are predicted to result in the absence of harmony in production practices, thereby limiting growth opportunities.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What Initiatives are New Companies Taking to Bolster Their Position in This Market?
“Investments in Technological Advancements for Development of Effective Pharmaceuticals”
Start-ups can focus on investment for the development of specialized and innovative products, including organic feeds enriched with specific nutrients targeting some prevalent diseases in aquaculture. Providing unique solutions can help new players get a competitive edge.
Country-wise Insights
According to a Fact.MR report, a market research and competitive intelligence provider, East Asia is predicted to contribute 50.1% share of global market revenue by 2034. This dominance is attributed to the increased adoption of qualitative feeds and pharmaceuticals for fish health and safety as demand for seafood is increasing in the region.
Why is the United States a Key Market in This Business?
“Increasing Consumption of Seafood Generating Demand for Healthier Aquatic Species”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 190.9 Million |
| Growth Rate (2024 to 2034) | 4.1% CAGR |
| Projected Value (2034F) | US$ 286 Million |
The United States is predicted to hold 63.4% share of the North American market by 2034. Shifting consumer preferences to more sustainable and healthier food options is predicted to cushion demand for seafood. Aquaculture serves as the prominent source of seafood and fish production to match this demand. This boosts the need for quality aquaculture feed and pharmaceuticals. These products are essential for the health and growth of several farm species.
The growth of the aquaculture industry is predicted to generate demand for specialized feed and pharmaceuticals customized for several species.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
As per the study published by Fact.MR, a market research and competitive intelligence provider, the worldwide demand for crab byproducts is increasing in aquaculture for waste reduction and sustainability. Crab processing can generate waste in the form of residues and shells. Reusing these products is predicted to promote a sustainability approach, thus attracting aquaculture feed and pharmaceutical market trends.
Which Product Type is Gaining Ground among End Users?
“Rising Adoption of Pharmaceuticals & Biologics as Immunity Boosters”
| Attribute | Pharmaceuticals & Biologics |
|---|---|
| Segment Value (2024E) | US$ 795.9 Million |
| Growth Rate (2024 to 2034) | 7.2% CAGR |
| Projected Value (2034F) | US$ 1.6 Billion |
Pharmaceuticals and biologics are forecasted to account for 78.5% share of the global market by 2034. Anti-inflammatories, antifungals, antibiotics, and other therapeutics are used in aquaculture feed and pharmaceuticals for aquatic species. Several vaccines are also predicted to gain traction for strengthening immunity and preventing viral infections among farm species. Several oral medications are also used as immunity boosters for species in the aquaculture industry.
Which Species is Forecasted to Hold a Dominant Position in the Market?
“High Nutritional Value of Carps Pushing Their Widespread Adoption”
| Attribute | Carp |
|---|---|
| Segment Value (2024E) | US$ 425.8 Million |
| Growth Rate (2024 to 2034) | 7.7% CAGR |
| Projected Value (2034F) | US$ 894.1 Million |
Carps are projected to hold 43.8% aquaculture feed and pharmaceutical market share by 2034. Carp byproducts, including residue and shells, are rich in nutrients, including amino acids, chitin, proteins, lipids, and minerals (calcium, phosphorus, etc.). These components increase their value as feed supplements for several aquaculture species.
Chitin is contained in crab shells, which is generally processed into chitosan and finds application in aquaculture health products and pharmaceuticals. Its antimicrobial properties help in disease prevention, controlling parasites, and wound healing in aquaculture species.
Competitive Landscape
Providers of aquaculture feed and pharmaceuticals are adopting multiple strategies to achieve respective purposes, including effective management of supply chain systems, ensuring product quality control, and innovation.
Key players in the aquaculture feed and pharmaceutical market are AgriProtein Holdings Ltd., InnovaFeed, Beta Hatch, Nutrition Technologies Group, Mutatec, Zoetis, Inc., Ridley Corporation Ltd., Schouw & Co., Merck & Co Inc., Aller Aqua A/A, Biomin Holding GmbH, Avanti Feeds Ltd., Alltech Inc., Norel S.A., Beneo GmbH, Akretting AS, Neovia Vietnam, Growel Feeds Pvt. Ltd., and Novus International Inc.
Segmentation of Aquaculture Feed and Pharmaceutical Market Research
-
By Product Type :
- Pharmaceuticals & Biologics
- Medicated Feed
-
By Species :
- Mollusks
- Shrimp
- Salmon
- Carp
- Tilapia
- Catfish
-
By Region :
- North America
- Europe
- East Asia
- Latin America
- Middle East & Africa
- South Asia & Oceania
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Key Market Trends
- 4. Key Success Factors
- 5. Market Background
- 6. Global Market Volume (Units) Analysis 2018 to 2023 and Forecast, 2024 to 2034
- 7. Global Market - Pricing Analysis
- 8. Global Market Value Analysis 2018 to 2023 and Forecast, 2024 to 2034
- 9. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Product Type
- 9.1. Pharmaceuticals & Biologics
- 9.2. Medicated Feed
- 10. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Species
- 10.1. Mollusks
- 10.2. Shrimp
- 10.3. Salmon
- 10.4. Carp
- 10.5. Tilapia
- 10.6. Catfish
- 11. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Region
- 11.1. North America
- 11.2. Latin America
- 11.3. Europe
- 11.4. East Asia
- 11.5. South Asia
- 11.6. Oceania
- 11.7. Middle East and Africa (MEA)
- 12. North America Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 13. Latin America Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 14. Europe Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 15. South Asia Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 16. East Asia Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 17. Oceania Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 18. Middle East and Africa Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 19. Key and Emerging Countries Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 20. Market Structure Analysis
- 21. Competition Analysis
- 21.1. AgriProtein Holdings Ltd.
- 21.2. InnovaFeed
- 21.3. Beta Hatch
- 21.4. Nutrition Technologies Group
- 21.5. Mutatec
- 21.6. Zoetis, Inc.
- 21.7. Ridley Corporation Ltd.
- 21.8. Schouw & Co.
- 21.9. Merck & Co Inc.
- 21.10. Aller Aqua A/A
- 21.11. Biomin Holding GmbH
- 21.12. Avanti Feeds Ltd.
- 21.13. Alltech Inc.
- 21.14. Norel S.A.
- 21.15. Beneo GmbH
- 21.16. Akretting AS
- 21.17. Neovia Vietnam
- 21.18. Growel Feeds Pvt. Ltd.
- 21.19. Novus International Inc.
- 22. Assumptions and Acronyms Used
- 23. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (‘000 Units) Analysis and Opportunity Assessment 2018 to 2034, By Product Type
Table 02: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product Type
Table 03: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Species
Table 04: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Region
Table 05: North America Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 06: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product Type
Table 07: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Species
Table 08: Latin America Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 09: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product Type
Table 10: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Species
Table 11: Europe Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 12: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product Type
Table 13: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Species
Table 14: South Asia Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 15: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product Type
Table 16: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Species
Table 17: East Asia Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 18: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product Type
Table 19: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Species
Table 20: Oceania Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 21: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product Type
Table 22: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Species
Table 23: Middle East and Africa Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 24: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product Type
Table 25: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Species
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Volume (in 000' Units) Analysis, 2018 to 2023
Figure 02: Global Market Volume Forecast (in 000' Units), 2024 to 2034
Figure 03: Pricing Analysis (US$) Per Product Type, By Region, 2023
Figure 04: Pricing Analysis (US$) Per Product Type, By Region, 2023
Figure 05: Global Market Value Analysis (US$ Mn), 2018 to 2023
Figure 06: Global Market Value Forecast (US$ Mn), 2024 to 2034
Figure 07: Global Market Absolute $ Opportunity, 2024 to 2034
Figure 08: Global Market Share Analysis (%), By Product Type, 2024 to 2034
Figure 09: Global Market Y-o-Y Analysis (%), By Product Type, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 11: Global Market Share Analysis (%), By Species, 2024 to 2034
Figure 12: Global Market Y-o-Y Analysis (%), By Species, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by Species, 2024 to 2034
Figure 14: Global Market Share Analysis (%), By Region, 2024 to 2034
Figure 15: Global Market Y-o-Y Analysis (%), By Region, 2024 to 2034
Figure 16: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 17: North America Market Value Share, By Product Type, 2024 (E)
Figure 18: North America Market Value Share, By Species, 2024 (E)
Figure 19: North America Market Value Share, By Country, 2024 (E)
Figure 20: North America Market Value Analysis (US$ Mn), 2018 to 2023
Figure 21: North America Market Value Forecast (US$ Mn), 2024 to 2034
Figure 22: North America Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 23: North America Market Attractiveness Analysis by Species, 2024 to 2034
Figure 24: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 25: Latin America Market Value Share, By Product Type, 2024 (E)
Figure 26: Latin America Market Value Share, By Species, 2024 (E)
Figure 27: Latin America Market Value Share, By Country, 2024 (E)
Figure 28: Latin America Market Value Analysis (US$ Mn), 2018 to 2023
Figure 29: Latin America Market Value Forecast (US$ Mn), 2024 to 2034
Figure 30: Latin America Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 31: Latin America Market Attractiveness Analysis by Species, 2024 to 2034
Figure 32: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 33: Europe Market Value Share, By Product Type, 2024 (E)
Figure 34: Europe Market Value Share, By Species, 2024 (E)
Figure 35: Europe Market Value Share, By Country, 2024 (E)
Figure 36: Europe Market Value Analysis (US$ Mn), 2018 to 2023
Figure 37: Europe Market Value Forecast (US$ Mn), 2024 to 2034
Figure 38: Europe Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 39: Europe Market Attractiveness Analysis by Species, 2024 to 2034
Figure 40: Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 41: South Asia Market Value Share, By Product Type, 2024 (E)
Figure 42: South Asia Market Value Share, By Species, 2024 (E)
Figure 43: South Asia Market Value Share, By Country, 2024 (E)
Figure 44: South Asia Market Value Analysis (US$ Mn), 2018 to 2023
Figure 45: South Asia Market Value Forecast (US$ Mn), 2024 to 2034
Figure 46: South Asia Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 47: South Asia Market Attractiveness Analysis by Species, 2024 to 2034
Figure 48: South Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 49: East Asia Market Value Share, By Product Type, 2024 (E)
Figure 50: East Asia Market Value Share, By Species, 2024 (E)
Figure 51: East Asia Market Value Share, By Country, 2024 (E)
Figure 52: East Asia Market Value Analysis (US$ Mn), 2018 to 2023
Figure 53: East Asia Market Value Forecast (US$ Mn), 2024 to 2034
Figure 54: East Asia Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 55: East Asia Market Attractiveness Analysis by Species, 2024 to 2034
Figure 56: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 57: Oceania Market Value Share, By Product Type, 2024 (E)
Figure 58: Oceania Market Value Share, By Species, 2024 (E)
Figure 59: Oceania Market Value Share, By Country, 2024 (E)
Figure 60: Oceania Market Value Analysis (US$ Mn), 2018 to 2023
Figure 61: Oceania Market Value Forecast (US$ Mn), 2024 to 2034
Figure 62: Oceania Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 63: Oceania Market Attractiveness Analysis by Species, 2024 to 2034
Figure 64: Oceania Market Attractiveness Analysis by Country, 2024 to 2034
Figure 65: Middle East and Africa Market Value Share, By Product Type, 2024 (E)
Figure 66: Middle East and Africa Market Value Share, By Species, 2024 (E)
Figure 67: Middle East and Africa Market Value Share, By Country, 2024 (E)
Figure 68: Middle East and Africa Market Value Analysis (US$ Mn), 2018 to 2023
Figure 69: Middle East and Africa Market Value Forecast (US$ Mn), 2024 to 2034
Figure 70: Middle East and Africa Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 71: Middle East and Africa Market Attractiveness Analysis by Species, 2024 to 2034
Figure 72: Middle East and Africa Market Attractiveness Analysis by Country, 2024 to 2034
Figure 73: UNITED STATES Market Value Analysis (US$ Mn), 2024 & 2034
Figure 74: UNITED STATES Market Value Share, By Product Type, 2024 (E)
Figure 75: UNITED STATES Market Value Share, By Species, 2024 (E)
Figure 76: Canada Market Value Analysis (US$ Mn), 2024 & 2034
Figure 77: Canada Market Value Share, By Product Type, 2024 (E)
Figure 78: Canada Market Value Share, By Species, 2024 (E)
Figure 79: Mexico Market Value Analysis (US$ Mn), 2024 & 2034
Figure 80: Mexico Market Value Share, By Product Type, 2024 (E)
Figure 81: Mexico Market Value Share, By Species, 2024 (E)
Figure 82: Brazil Market Value Analysis (US$ Mn), 2024 & 2034
Figure 83: Brazil Market Value Share, By Product Type, 2024 (E)
Figure 84: Brazil Market Value Share, By Species, 2024 (E)
Figure 85: UNITED KINGDOM Market Value Analysis (US$ Mn), 2024 & 2034
Figure 86: UNITED KINGDOM Market Value Share, By Product Type, 2024 (E)
Figure 87: UNITED KINGDOM Market Value Share, By Species, 2024 (E)
Figure 88: Germany Market Value Analysis (US$ Mn), 2024 & 2034
Figure 89: Germany Market Value Share, By Product Type, 2024 (E)
Figure 90: Germany Market Value Share, By Species, 2024 (E)
Figure 91: France Market Value Analysis (US$ Mn), 2024 & 2034
Figure 92: France Market Value Share, By Product Type, 2024 (E)
Figure 93: France Market Value Share, By Species, 2024 (E)
Figure 94: Italy Market Value Analysis (US$ Mn), 2024 & 2034
Figure 95: Italy Market Value Share, By Product Type, 2024 (E)
Figure 96: Italy Market Value Share, By Species, 2024 (E)
Figure 97: Spain Market Value Analysis (US$ Mn), 2024 & 2034
Figure 98: Spain Market Value Share, By Product Type, 2024 (E)
Figure 99: Spain Market Value Share, By Species, 2024 (E)
Figure 100: Russia Market Value Analysis (US$ Mn), 2024 & 2034
Figure 101: Russia Market Value Share, By Product Type, 2024 (E)
Figure 102: Russia Market Value Share, By Species, 2024 (E)
Figure 103: China Market Value Analysis (US$ Mn), 2024 & 2034
Figure 104: China Market Value Share, By Product Type, 2024 (E)
Figure 105: China Market Value Share, By Species, 2024 (E)
Figure 106: Japan Market Value Analysis (US$ Mn), 2024 & 2034
Figure 107: Japan Market Value Share, By Product Type, 2024 (E)
Figure 108: Japan Market Value Share, By Species, 2024 (E)
Figure 109: South Korea Market Value Analysis (US$ Mn), 2024 & 2034
Figure 110: South Korea Market Value Share, By Product Type, 2024 (E)
Figure 111: South Korea Market Value Share, By Species, 2024 (E)
Figure 112: India Market Value Analysis (US$ Mn), 2024 & 2034
Figure 113: India Market Value Share, By Product Type, 2024 (E)
Figure 114: India Market Value Share, By Species, 2024 (E)
Figure 115: ASEAN Market Value Analysis (US$ Mn), 2024 & 2034
Figure 116: ASEAN Market Value Share, By Product Type, 2024 (E)
Figure 117: ASEAN Market Value Share, By Species, 2024 (E)
Figure 118: Australia Market Value Analysis (US$ Mn), 2024 & 2034
Figure 119: Australia Market Value Share, By Product Type, 2024 (E)
Figure 120: Australia Market Value Share, By Species, 2024 (E)
Figure 121: New Zealand Market Value Analysis (US$ Mn), 2024 & 2034
Figure 122: New Zealand Market Value Share, By Product Type, 2024 (E)
Figure 123: New Zealand Market Value Share, By Species, 2024 (E)
Figure 124: GCC Countries Market Value Analysis (US$ Mn), 2024 & 2034
Figure 125: GCC Countries Market Value Share, By Product Type, 2024 (E)
Figure 126: GCC Countries Market Value Share, By Species, 2024 (E)
Figure 127: Turkey Market Value Analysis (US$ Mn), 2024 & 2034
Figure 128: Turkey Market Value Share, By Product Type, 2024 (E)
Figure 129: Turkey Market Value Share, By Species, 2024 (E)
Figure 130: South Africa Market Value Analysis (US$ Mn), 2024 & 2034
Figure 131: South Africa Market Value Share, By Product Type, 2024 (E)
Figure 132: South Africa Market Value Share, By Species, 2024 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the aquaculture feed and pharmaceutical market?
The global aquaculture feed and pharmaceutical market is pegged at US$ 999.4 million in 2024.
What valuation is the carp segment predicted to reach in 2024?
Demand for carp is set to reach a market value of US$ 425.8 million in 2024.
What is the forecasted valuation of the aquaculture feed and pharmaceutical market for 2034?
Demand for aquaculture feed and pharmaceuticals is forecasted to reach a market value of US$ 2.04 billion by the end of 2034.
At what rate is the demand for aquaculture feed and pharmaceuticals projected to increase?
The global market is projected to advance at 7.4% CAGR from 2024 to 2034.
What is the forecasted contribution of East Asia to the global market by 2034?
East Asia is projected to hold 50.1% share of the global market by 2034.
What portion of the market are pharmaceuticals & biologics projected to occupy?
The pharmaceuticals & biologics segment is projected to account for 78.5% share of global revenue by 2034.
Aquaculture Feed and Pharmaceutical Market